These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19005275)

  • 1. Lower levels of HIV-2 than HIV-1 in the female genital tract: correlates and longitudinal assessment of viral shedding.
    Hawes SE; Sow PS; Stern JE; Critchlow CW; Gottlieb GS; Kiviat NB
    AIDS; 2008 Nov; 22(18):2517-25. PubMed ID: 19005275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral excretion in cervicovaginal secretions of HIV-1-infected women receiving antiretroviral therapy.
    Debiaggi M; Zara F; Spinillo A; De Santolo A; Maserati R; Bruno R; Sacchi P; Achilli G; Pistorio A; Romero E; Filice G
    Eur J Clin Microbiol Infect Dis; 2001 Feb; 20(2):91-6. PubMed ID: 11305478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic Immune Activation and HIV Shedding in the Female Genital Tract.
    Spencer LY; Christiansen S; Wang CH; Mack WJ; Young M; Strickler HD; Anastos K; Minkoff H; Cohen M; Geenblatt RM; Karim R; Operskalski E; Frederick T; Homans JD; Landay A; Kovacs A
    J Acquir Immune Defic Syndr; 2016 Feb; 71(2):155-62. PubMed ID: 26334738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervicovaginal HIV-1 shedding in women taking antiretroviral therapy in Burkina Faso: a longitudinal study.
    Low AJ; Konate I; Nagot N; Weiss HA; Kania D; Vickerman P; Segondy M; Mabey D; Pillay D; Meda N; van de Perre P; Mayaud P;
    J Acquir Immune Defic Syndr; 2014 Feb; 65(2):237-45. PubMed ID: 24226060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 genital shedding is suppressed in the setting of high genital antiretroviral drug concentrations throughout the menstrual cycle.
    Sheth AN; Evans-Strickfaden T; Haaland R; Martin A; Gatcliffe C; Adesoye A; Omondi MW; Lupo LD; Danavall D; Easley K; Chen CY; Pau CP; Hart C; Ofotokun I
    J Infect Dis; 2014 Sep; 210(5):736-44. PubMed ID: 24643223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load.
    Cu-Uvin S; DeLong AK; Venkatesh KK; Hogan JW; Ingersoll J; Kurpewski J; De Pasquale MP; D'Aquila R; Caliendo AM
    AIDS; 2010 Oct; 24(16):2489-97. PubMed ID: 20736815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual HIV-1 RNA and HIV-1 DNA production in the genital tract reservoir of women treated with HAART: the prospective ANRS EP24 GYNODYN study.
    Launay O; Tod M; Tschöpe I; Si-Mohamed A; Bélarbi L; Charpentier C; Goujard C; Taburet AM; Lortholary O; Leroy V; Bélec L;
    Antivir Ther; 2011; 16(6):843-52. PubMed ID: 21900716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral treatment interruptions predict female genital shedding of genotypically resistant HIV-1 RNA.
    Graham SM; Jalalian-Lechak Z; Shafi J; Chohan V; Deya RW; Jaoko W; Mandaliya KN; Peshu NM; Overbaugh J; McClelland RS
    J Acquir Immune Defic Syndr; 2012 Aug; 60(5):511-8. PubMed ID: 22592588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervicovaginal HIV-1 and herpes simplex virus type 2 shedding during genital ulcer disease episodes.
    LeGoff J; Weiss HA; Gresenguet G; Nzambi K; Frost E; Hayes RJ; Mabey DC; Malkin JE; Mayaud P; Belec L
    AIDS; 2007 Jul; 21(12):1569-78. PubMed ID: 17630552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal assessment of HIV-1 and HSV-2 shedding in the genital tract of West African women.
    Nagot N; Foulongne V; Becquart P; Mayaud P; Konate I; Ouedraogo A; Defer MC; Weiss H; Van de Perre P; Segondy M
    J Acquir Immune Defic Syndr; 2005 Aug; 39(5):632-4. PubMed ID: 16044019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of genital shedding of herpes simplex virus type 2 and HIV-1 among sex workers in rural Zimbabwe.
    Cowan FF; Pascoe SJ; Barlow KL; Langhaug LF; Jaffar S; Hargrove JW; Robinson NJ; Latif AS; Bassett MT; Wilson D; Brown DW; Hayes RJ
    AIDS; 2006 Jan; 20(2):261-7. PubMed ID: 16511420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load.
    Cu-Uvin S; Caliendo AM
    AIDS; 2011 Mar; 25(6):880-1. PubMed ID: 21412068
    [No Abstract]   [Full Text] [Related]  

  • 13. Determinants of HIV-1 shedding in the genital tract of women.
    Kovacs A; Wasserman SS; Burns D; Wright DJ; Cohn J; Landay A; Weber K; Cohen M; Levine A; Minkoff H; Miotti P; Palefsky J; Young M; Reichelderfer P; ;
    Lancet; 2001 Nov; 358(9293):1593-601. PubMed ID: 11716886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, Magnitude, and Correlates of HIV-1 Genital Shedding in Women on Antiretroviral Therapy.
    King CC; Ellington SR; Davis NL; Coombs RW; Pyra M; Hong T; Mugo N; Patel RC; Lingappa JR; Baeten JM; Kourtis AP;
    J Infect Dis; 2017 Dec; 216(12):1534-1540. PubMed ID: 29240922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-associated genital tract virus and vertical transmission of human immunodeficiency virus type 1 in antiretroviral-experienced women.
    Tuomala RE; O'Driscoll PT; Bremer JW; Jennings C; Xu C; Read JS; Matzen E; Landay A; Zorrilla C; Blattner W; Charurat M; Anderson DJ;
    J Infect Dis; 2003 Feb; 187(3):375-84. PubMed ID: 12552421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herpes simplex virus type 2 (HSV-2) genital shedding in HSV-2-/HIV-1-co-infected women receiving effective combination antiretroviral therapy.
    Péré H; Rascanu A; LeGoff J; Matta M; Bois F; Lortholary O; Leroy V; Launay O; Bélec L;
    Int J STD AIDS; 2016 Mar; 27(3):178-85. PubMed ID: 25769886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-DNA in the genital tract of women on long-term effective therapy is associated to residual viremia and previous AIDS-defining illnesses.
    Prazuck T; Chaillon A; Avettand-Fènoël V; Caplan AL; Sayang C; Guigon A; Niang M; Barin F; Rouzioux C; Hocqueloux L
    PLoS One; 2013; 8(8):e69686. PubMed ID: 23990886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and risk factors of cervicovaginal HIV shedding among HIV-1 and HIV-2 infected women in Dakar, Senegal.
    Seck K; Samb N; Tempesta S; Mulanga-Kabeya C; Henzel D; Sow PS; Coll-Seck A; Mboup S; Ndoye I; Delaporte E
    Sex Transm Infect; 2001 Jun; 77(3):190-3. PubMed ID: 11402227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infectious correlates of HIV-1 shedding in the female upper and lower genital tracts.
    Coleman JS; Hitti J; Bukusi EA; Mwachari C; Muliro A; Nguti R; Gausman R; Jensen S; Patton D; Lockhart D; Coombs R; Cohen CR
    AIDS; 2007 Mar; 21(6):755-9. PubMed ID: 17413697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genital tract human immunodeficiency virus type 1 (HIV-1) shedding and inflammation and HIV-1 env diversity in perinatal HIV-1 transmission.
    Panther LA; Tucker L; Xu C; Tuomala RE; Mullins JI; Anderson DJ
    J Infect Dis; 2000 Feb; 181(2):555-63. PubMed ID: 10669339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.